Login / Signup

A novel lytic phage exhibiting a remarkable in vivo therapeutic potential and higher antibiofilm activity against Pseudomonas aeruginosa.

Aliaa AbdelghafarAmira El-GaninyGhada ShakerMomen M Askoura
Published in: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2023)
Based on these findings, isolated phage vB_PaeM_PS3 could be potentially considered for treating of P. aeruginosa infections.
Keyphrases
  • pseudomonas aeruginosa
  • cystic fibrosis
  • biofilm formation
  • acinetobacter baumannii
  • drug resistant